{
    "2020-10-12": [
        [
            {
                "time": "",
                "orginal_text": "创新药三季度报告：创新力量集中于头部企业，全球首创新药取得突破，肿瘤药扎堆存风险",
                "features": {
                    "keywords": [
                        "创新药",
                        "三季度报告",
                        "头部企业",
                        "全球首创",
                        "肿瘤药",
                        "风险"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业周报-三季报前瞻：整体乐观 强者恒强",
                "features": {
                    "keywords": [
                        "医药生物",
                        "周报",
                        "三季报前瞻",
                        "整体乐观",
                        "强者恒强"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医疗保健专题报告：医药行业2020年三季报业绩前瞻",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "专题报告",
                        "医药行业",
                        "2020年",
                        "三季报",
                        "业绩前瞻"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}